DUGiDocs
Lang
català
español
English
Browse
All of DSpace
Communities & Collections
By Issue Date
Authors
Titles
Subjects
Sign in
UdG users
UdG identification
External users
Reset Password
Browsing by Author
Browsing by Author "Vázquez Martín, Alejandro"
Now showing items 1-5 of 5
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: gefitinib (Iressatrade mark)-induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)
2007
Article
Ferrer Soler, Laura
Vázquez Martín, Alejandro
Brunet i Vidal, Joan
Menéndez Menéndez, Javier Abel
et al.
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling
2008
Article
Oliveras Ferrarós, Cristina
Vázquez Martín, Alejandro
Colomer, Ramon
Llorens Duran, Rafael de
et al.
Interferon/STAT1 and neuregulin signaling pathways are exploratory biomarkers of cetuximab (Erbitux®) efficacy in KRAS wild-type squamous carcinomas: A pathway-based analysis of whole human-genome microarray data from cetuximab-adapted tumor cell-line models
2011
Article
Oliveras Ferrarós, Cristina
Vázquez Martín, Alejandro
Queralt, Bernardo
Adrados, Manuel
et al.
Transcriptional upregulation of HER2 expression in the absence of HER2 gene amplification results in cetuximab resistance that is reversed by trastuzumab treatment
2012
Article
Oliveras Ferrarós, Cristina
Massaguer i Vall-llovera, Anna
Vázquez Martín, Alejandro
Carrion Salip, Dolors
et al.
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts
2012-04
Article
Cufí González, Sílvia
Corominas Faja, Bruna
Vázquez Martín, Alejandro
Oliveras Ferrarós, Cristina
et al.
Now showing items 1-5 of 5
Browse
All of DSpace
Communities & Collections
By Issue Date
Authors
Titles
Subjects
idioma
català
español
English
Contacte
Avís Legal